Affiliation: Department of Pediatrics, Duke University School of Medicine, NC, USA

Aswathy Shailaja, Ph.D., is presently employed as a Postdoctoral Associate at Department of Pediatrics, Duke University School of Medicine. Her current research focuses on the studying the impact of oxysterols on neonatal inflammation and the modulation of LXR signaling pathway. She obtained her Ph.D. from Clemson University in 2020. During her initial postdoctoral training at Department of Pediatrics at Renaissance School of Medicine, Stony Brook University, she investigated the potential of phosphodiesterase inhibitor pentoxifylline (PTX) in the modulation of anti-inflammatory responses and brain protection in neonatal bacterial sepsis mouse model.